Our Research Services team works collaboratively with clients to provide in vitro hepatic modeling solutions. And as the world’s premier supplier of ADME-Tox model systems, including hepatocytes and subcellular fractions, BioIVT enables scientists to better understand the pharmacokinetics and drug metabolism of newly discovered compounds and the effects on disease processes. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®.
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Arsenal Capital Partners | arsenalcapital.com |
Mentions in press and media 1
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
Reviews 0
FAQ about Bioreclamation
Who has invested in Bioreclamation?
Parsers VC lists 2 investors of Bioreclamation, among them Arsenal Capital Partners.
Is Bioreclamation still active?
Yes, Bioreclamation is active.